1. Altin S.E. et al. Seasonal variation in U.S. hospitalizations for chronic limb-threatening ischemia//Catheterization and Cardiovascular Interventions. John Wiley and Sons Inc, 2020. Vol. 96, N 7. P. 1473 - 1480.

2. Agarwal S., Sud K., Shishehbor M.H. Nationwide Trends of Hospital Admission and Outcomes among Critical Limb Ischemia Patients from 2003 - 2011//J Am Coll Cardiol. Elsevier USA, 2016. Vol. 67, N 16. P. 1901 - 1913.

3. Conte M.S. et al. Global vascular guidelines on the management of chronic limb-threatening ischemia//J Vasc Surg. Mosby Inc., 2019. Vol. 69, N 6. P. 3S - 125S.e40.

4. Lazarides M.K. et al. Diagnostic criteria and treatment of Buerger's disease: A review//International Journal of Lower Extremity Wounds. 2006. Vol. 5, N 2. P. 89 - 95.

5. Vanoli M. et al. Takayasu's arteritis: A study of 104 Italian patients//Arthritis Care Res (Hoboken). 2005. Vol. 53, N 1. P. 100 - 107.

6. Arnaud L. et al. Takayasu arteritis in France: A single-center retrospective study of 82 cases comparing white, North African, and black patients//Medicine. Lippincott Williams and Wilkins, 2010. Vol. 89, N 1. P. 1 - 17.

7. M. et al. Editor's Choice - European Society for Vascular Surgery (ESVS) 2020 Clinical Practice Guidelines on the Management of Acute Limb Ischaemia//European Journal of Vascular and Endovascular Surgery. W.B. Saunders Ltd, 2020. Vol. 59, N 2. P. 173 - 218.

8. Magee R. et al. Growth and Risk Factors for Expansion of Dilated Popliteal Arteries//European Journal of Vascular and Endovascular Surgery. 2010. Vol. 39, N 5. P. 606 - 611.

9. Putko R.M. et al. SARS-CoV-2 and limb ischemia: A systematic review//Journal of Clinical Orthopaedics and Trauma. Elsevier B.V., 2021. Vol. 12, N 1. P. 194 - 199.

10. Mills J.L. et al. The society for vascular surgery lower extremity threatened limb classification system: Risk stratification based on Wound, Ischemia, and foot Infection (WIfI)//J Vasc Surg. Mosby Inc., 2014. Vol. 59, N 1.

11. Tyrrell M.R., Wolfe J.H.N. Critical leg ischaemia: an appraisal of clinical definitions. Joint Vascular Research Group//Br J Surg. Br J Surg, 1993. Vol. 80, N 2. P. 177 - 180.

12. Norgren L. et al. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II)//European Journal of Vascular and Endovascular Surgery. 2007. Vol. 33, N 1 SUPPL.

13. Lees T. et al. International variations in infrainguinal bypass surgery - A VASCUNET Report//European Journal of Vascular and Endovascular Surgery. W.B. Saunders Ltd, 2012. Vol. 44, N 2. P. 185 - 192.

14. Kannel W.B. et al. Intermittent claudication. Incidence in the Framingham Study//Circulation. Circulation, 1970. Vol. 41, N 5. P. 875 - 883.

15. Brahmandam A. et al. Discrepancy in Outcomes after Revascularization for Chronic Limb-Threatening Ischemia Warrants Separate Reporting of Rest Pain and Tissue Loss//Ann Vasc Surg. Elsevier Inc., 2021. Vol. 70. P. 237 - 244.

16. Tsai F.W. et al. Skin perfusion pressure of the foot is a good substitute for toe pressure in the assessment of limb ischemia//J Vasc Surg. 2000. Vol. 32, N 1. P. 32 - 36.

17. Meloni M. et al. Prevalence, clinical aspects and outcomes in a large cohort of persons with diabetic foot disease: Comparison between neuropathic and ischemic ulcers//J Clin Med. MDPI, 2020. Vol. 9, N 6. P. 1 - 11.

18. Cranley J.J. Ischemic rest pain//Arch Surg. Arch Surg, 1969. Vol. 98, N 2. P. 187 - 188.

19. Provan. Pitfalls in the diagnosis of leg pain - PubMed [Electronic resource]. URL: https://pubmed.ncbi.nlm.nih.gov/229951/ (accessed: 23.02.2022).

20. Darling J.D. et al. Predictive ability of the Society for Vascular Surgery Wound, Ischemia, and foot Infection (WIfI) classification system following infrapopliteal endovascular interventions for critical limb ischemia//Journal of Vascular Surgery. Mosby Inc., 2016. Vol. 64, N 3. P. 616 - 622.

21. Yotsu R.R. et al. Comparison of characteristics and healing course of diabetic foot ulcers by etiological classification: Neuropathic, ischemic, and neuro-ischemic type//J Diabetes Complications. Elsevier Inc., 2014. Vol. 28, N 4. P. 528 - 535.

22. Gardner S.E., Frantz R.A. Wound bioburden and infection-related complications in diabetic foot ulcers//Biological Research for Nursing. 2008. Vol. 10, N 1. P. 44 - 53.

23. Dormandy J. et al. Prospective study of 713 below-knee amputations for ischaemia and the effect of a prostacyclin analogue on healing//British Journal of Surgery. 1994. Vol. 81. 33 - 37 p.

24. Criqui M.H. et al. The sensitivity, specificity, and predictive value of traditional clinical evaluation of peripheral arterial disease: results from noninvasive testing in a defined population//Circulation. Circulation, 1985. Vol. 71, N 3. P. 516 - 522.

25. Milne W.K., Worster A. Does the Clinical Examination Predict Lower Extremity Peripheral Arterial Disease?//Annals of Emergency Medicine. 2009. Vol. 54, N 5. P. 748 - 750.

26. Mcgee S.R., Boyko E.J. Physical Examination and Chronic Lower-Extremity Ischemia A Critical Review//Arch Intern Med. 1998. Vol. 158. 1357 - 1364 p.

27. Salaun P. et al. Comparison of Ankle Pressure, Systolic Toe Pressure, and Transcutaneous Oxygen Pressure to Predict Major Amputation After 1 Year in the COPART Cohort//Angiology. SAGE Publications Inc., 2019. Vol. 70, N 3. P. 229 - 236.

28. Met R. et al. Diagnostic performance of computed tomography angiography in peripheral arterial disease: a systematic review and meta-analysis//JAMA. JAMA, 2009. Vol. 301, N 4. P. 415 - 424.

29. Collins R. et al. A systematic review of duplex ultrasound, magnetic resonance angiography and computed tomography angiography for the diagnosis and assessment of symptomatic, lower limb peripheral arterial disease HTA Health Technology Assessment NHS R&D HTA Programme www.hta.ac.uk//Health Technol Assess (Rockv). 2007. Vol. 11, N 20.

30. Lapeyre M. et al. Assessment of critical limb ischemia in patients with diabetes: Comparison of MR angiography and digital subtraction angiography//American Journal of Roentgenology. 2005. Vol. 185, N 6. P. 1641 - 1650.

31. Sultan S., Tawfick W., Hynes N. Ten-year technical and clinical outcomes in TransAtlantic Inter-Society Consensus II infrainguinal C/D lesions using duplex ultrasound arterial mapping as the sole imaging modality for critical lower limb ischemia//J Vasc Surg. 2013. Vol. 57, N 4. P. 1038 - 1045.

32. Menke J., Larsen J. Meta-analysis: Accuracy of contrast-enhanced magnetic resonance angiography for assessing steno-occlusions in peripheral arterial disease//Ann Intern Med. Ann Intern Med, 2010. Vol. 153, N 5. P. 325 - 334.

33. Heijenbrok-Kal M.H., Kock M.C.J.M., Hunink M.G.M. Lower extremity arterial disease: Multidetector CT angiography - Meta-analysis//Radiology. 2007. Vol. 245, N 2. P. 433 - 439.

34. Seeger J.M., Schmidt J.H., Flynn T.C. Preoperative saphenous and cephalic vein mapping as an adjunct to reconstructive arterial surgery//Ann Surg. Ann Surg, 1987. Vol. 205, N 6. P. 733 - 739.

35. Soden P.A. et al. Regional variation in patient selection and treatment for lower extremity vascular disease in the Vascular Quality Initiative//Journal of Vascular Surgery. Mosby Inc., 2017. Vol. 65, N 1. P. 108 - 118.

36. Lee M.S. et al. Clinical Outcomes of Patients With Critical Limb Ischemia who Undergo Routine Coronary Angiography and Subsequent Percutaneous Coronary Intervention//J INVASIVE CARDIOL. 2015. Vol. 27, N 4. 213 - 217 p.

37. Nishijima A. et al. Coronary Artery Disease in Patients with Critical Limb Ischemia Undergoing Major Amputation or Not//Plast Reconstr Surg Glob Open. Lippincott Williams and Wilkins, 2017. Vol. 5, N 6.

38. Krievins D. et al. Diagnosis of silent coronary ischemia with selective coronary revascularization might improve 2-year survival of patients with critical limb-threatening ischemia//Journal of Vascular Surgery. Elsevier Inc., 2021. Vol. 74, N 4. P. 1261 - 1271.

39. Choi B.G. et al. Long-term outcomes of peripheral arterial disease patients with significant coronary artery disease undergoing percutaneous coronary intervention//PLoS One. Public Library of Science, 2021. Vol. 16, N 5 May.

40. Polyantsev A.A. et al. Vstrechaemost' erozivno-yazvennykh porazhenii zheludochno-kishechnogo trakta i krovotechenii u bol'nykh, operirovannykh na arteriyakh nizhnikh konechnostei po povodu kriticheskoi ishemii//Khirurgiia (Sofiia). NLM (Medline), 2021. N 7. P. 57 - 64.

41. Velescu A. et al. Anemia Increases Mortality after Open or Endovascular Treatment in Patients with Critical Limb Ischemia: A Retrospective Analysis//European Journal of Vascular and Endovascular Surgery. W.B. Saunders Ltd, 2016. Vol. 51, N 4. P. 543 - 549.

42. Yun W.S. et al. Prevalence of asymptomatic critical carotid artery stenosis in korean patients with chronic atherosclerotic lower extremity ischemia: Is a screening carotid duplex ultrasonography worthwhile?//J Korean Med Sci. 2010. Vol. 25, N 8. P. 1167 - 1170.

43. Li Z. et al. Prevalence of asymptomatic carotid artery stenosis in Chinese patients with lower extremity peripheral arterial disease: A cross-sectional study on 653 patients//BMJ Open. BMJ Publishing Group, 2021. Vol. 11, N 4.

44. Aboyans V. et al. 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS)//European Heart Journal. Oxford University Press, 2018. Vol. 39, N 9. P. 763 - 816.

45. Nickinson A.T.O. et al. A systematic review investigating the identification, causes, and outcomes of delays in the management of chronic limb-threatening ischemia and diabetic foot ulceration//Journal of Vascular Surgery. Mosby Inc., 2020. Vol. 71, N 2. P. 669 - 681.e2.

46. Hinchliffe R.J. et al. IWGDF guidance on the diagnosis, prognosis and management of peripheral artery disease in patients with foot ulcers in diabetes//Diabetes Metab Res Rev. John Wiley and Sons Ltd, 2016. Vol. 32. P. 37 - 44.

47. Hertzer N.R., Block P.C. PAD guidelines: ACC/AHA guidelines for the management of patients with peripheral arterial disease (lower extremity, renal mesenteric, and abdominal aortic)//ACC Cardiosource Review Journal. 2006. Vol. 15, N 5. P. 14 - 17.

48. Crawford. Aortoiliac occlusive disease: factors influencing survival and function following reconstructive operation over a twenty-five-year period - PubMed [Electronic resource]. URL: https://pubmed.ncbi.nlm.nih.gov/7313940/ (accessed: 23.02.2022).

49. Chiu K.W.H. et al. Review of Direct Anatomical Open Surgical Management of Atherosclerotic Aorto-Iliac Occlusive Disease//European Journal of Vascular and Endovascular Surgery. 2010. Vol. 39, N 4. P. 460 - 471.

50. Bosch J.L., Hunink M.G.M. Meta-analysis of the results of percutaneous transluminal angioplasty and stent placement for aortoiliac occlusive disease//Radiology. Radiology, 1997. Vol. 204, N 1. P. 87 - 96.

51. . et al. Ricanalizzazione delle occlusioni trombotiche arteriose mediante trombectomia rotazionale//Radiologia Medica. 2011. Vol. 116, N 6. P. 932 - 944.

52. Wissgott C., Kamusella P., Andresen R. Treatment of chronic occlusions of the iliac or femoropopliteal arteries with mechanical rotational catheters//RoFo Fortschritte auf dem Gebiet der Rontgenstrahlen und der Bildgebenden Verfahren. 2011. Vol. 183, N 10. P. 945 - 951.

53. Silingardi R. et al. Mechanical thrombectomy in in-stent restenosis: preliminary experience at the iliac and femoropopliteal arteries with the Rotarex System//J Cardiovasc Surg. 2010. Vol. 51, N 4. 543 - 50 p.

54. Nguyen B.N. et al. Postoperative complications after common femoral endarterectomy//Journal of Vascular Surgery. Mosby Inc., 2015. Vol. 61, N 6. P. 1489 - 1494.e1.

55. Siracuse J.J. et al. Endovascular treatment of the common femoral artery in the Vascular Quality Initiative//Journal of Vascular Surgery. Mosby Inc., 2017. Vol. 65, N 4. P. 1039 - 1046.

56. Malgor R.D. et al. Common femoral artery endarterectomy for lower-extremity ischemia: Evaluating the need for additional distal limb revascularization//Ann Vasc Surg. 2012. Vol. 26, N 7. P. 946 - 956.

57. Ballotta E. et al. Common femoral artery endarterectomy for occlusive disease: An 8-year single- center prospective study//Surgery. 2010. Vol. 147, N 2. P. 268 - 274.

58. Kang J.L. et al. Common femoral artery occlusive disease: Contemporary results following surgical endarterectomy//J Vasc Surg. Mosby Inc., 2008. Vol. 48, N 4.

59. Bonvini R.F. et al. Angioplasty and provisional stent treatment of common femoral artery lesions//Journal of Vascular and Interventional Radiology. 2013. Vol. 24, N 2. P. 175 - 183.

60. Deloose K. et al. Endovascular treatment for the common femoral artery: Is there a challenger to open surgery?//Journal of Cardiovascular Surgery. Edizioni Minerva Medica, 2019. Vol. 60, N P. 8 - 13.

61. Y. et al. Stenting or Surgery for De Novo Common Femoral Artery Stenosis//JACC Cardiovasc Interv. Elsevier Inc., 2017. Vol. 10, N 13. P. 1344 - 1354.

62. Linni K. et al. Bioabsorbable stent implantation vs. common femoral artery endarterectomy: Early results of a randomized trial//Journal of Endovascular Therapy. Allen Press Publishing Services, 2014. Vol. 21, N 4. P. 493 - 502.

63. Siracuse J.J. et al. Comparison of open and endovascular treatment of patients with critical limb ischemia in the Vascular Quality Initiative//Journal of Vascular Surgery. Mosby Inc., 2016. Vol. 63, N 4. P. 958 - 965.e1.

64. Humbarger O. et al. Broad variation in prosthetic conduit use for femoral-popliteal bypass is not justified on the basis of contemporary outcomes favoring autologous great saphenous vein//Journal of Vascular Surgery. Mosby Inc., 2019. Vol. 70, N 5. P. 1514 - 1523.e2.

65. SVS VQI 2016. SVS PSO PATIENT SAFETY ORGANIZATION 2016 Detailed Annual Report VASCULAR QUALITY INITIATIVE.

66. Swedvasc 2020. Nationella kvalitetsregistret .

67. Davies M.G. et al. Impact of runoff on superficial femoral artery endoluminal interventions for rest pain and tissue loss//J Vasc Surg. Mosby Inc., 2008. Vol. 48, N 3.

68. Lee H.Y. et al. The effect of severe femoropopliteal arterial calcification on the treatment outcome of femoropopliteal intervention in patients with ischemic tissue loss//Vasc Specialist Int. Korean Society for Vascular Surgery, 2020. Vol. 36, N 2. P. 96 - 104.

69. Park U.J., Kim H.T., Roh Y.N. Impact of Tibial Runoff on Outcomes of Endovascular Treatment for Femoropopliteal Atherosclerotic Lesions//Vasc Endovascular Surg. SAGE Publications Inc., 2018. Vol. 52, N 7. P. 498 - 504.

70. Hiramori S. et al. Impact of runoff grade after endovascular therapy for femoropopliteal lesions//J Vasc Surg. 2014. Vol. 59, N 3. P. 720 - 727.

71. Tokuda T. et al. The Impact of Femoropopliteal Artery Calcium Score after Endovascular Treatment//Ann Vasc Surg. Elsevier Inc., 2020. Vol. 66. P. 543 - 553.

72. Smith B.M. et al. Subintimal angioplasty for superficial femoral artery occlusion: poor patency in critical ischaemia//Ann R Coll Surg Engl. Ann R Coll Surg Engl, 2005. Vol. 87, N 5. P. 361 - 365.

73. Bradbury A.W. et al. Multicentre randomised controlled trial of the clinical and cost-effectiveness of a bypass-surgery-first versus a balloon-angioplasty-first revascularisation strategy for severe limb ischaemia due to infrainguinal disease. The Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial//Health Technol Assess (Rockv). 2010. Vol. 14, N 14. P. 1 - 236.

74. Bradbury A.W. et al. Bypass versus angioplasty in severe ischaemia of the leg (BASIL): Multicentre, randomised controlled trial//Lancet. Elsevier B.V., 2005. Vol. 366, N 9501. P. 1925 - 1934.

75. Kodama A. et al. Editor's Choice - Relationship Between Global Limb Anatomic Staging System (GLASS) and Clinical Outcomes Following Revascularisation for Chronic Limb Threatening Ischaemia in the Bypass Versus Angioplasty in Severe Ischaemia of the Leg (BASIL)-1 Trial//European Journal of Vascular and Endovascular Surgery. W.B. Saunders Ltd, 2020. Vol. 60, N 5. P. 687 - 695.

76. Bosiers M. et al. ZILVERPASS Study: ZILVER PTX Stent vs Bypass Surgery in Femoropopliteal Lesions//Journal of Endovascular Therapy. SAGE Publications Inc., 2020. Vol. 27, N 2. P. 287 - 295.

77. Enzmann F.K. et al. Nitinol Stent Versus Bypass in Long Femoropopliteal Lesions: 2-Year Results of a Randomized Controlled Trial//JACC Cardiovasc Interv. Elsevier Inc., 2019. Vol. 12, N 24. P. 2541 - 2549.

78. Farber A. et al. Surgery or Endovascular Therapy for Chronic Limb-Threatening Ischemia//N Engl J Med. N Engl J Med, 2022.

79. Ambler G.K., Twine C.P. Graft type for femoro-popliteal bypass surgery//Cochrane Database of Systematic Reviews. John Wiley and Sons Ltd, 2018. Vol. 2018, N 2.

80. Klinkert P. et al. Saphenous vein versus PTFE for above-knee femoropopliteal bypass. A review of the literature//European Journal of Vascular and Endovascular Surgery. W.B. Saunders Ltd, 2004. Vol. 27, N 4. P. 357 - 362.

81. Nierlich P. et al. Alternative Venous Conduits for Below Knee Bypass in the Absence of Ipsilateral Great Saphenous Vein//European Journal of Vascular and Endovascular Surgery. W.B. Saunders Ltd, 2020. Vol. 60, N 3. P. 403 - 409.

82. Nierlich P. et al. Arm Vein versus Small Saphenous Vein for Lower Extremity Bypass in the Absence of Both Great Saphenous Veins//Ann Vasc Surg. Elsevier Inc., 2021. Vol. 70. P. 341 - 348.

83. Faries P.L. et al. The use of arm vein in lower-extremity revascularization: results of 520 procedures performed in eight years//J Vasc Surg. J Vasc Surg, 2000. Vol. 31, N 1 Pt 1. P. 50 - 59.

84. Chew D.K.W. et al. Autogenous composite vein bypass graft for infrainguinal arterial reconstruction//J Vasc Surg. J Vasc Surg, 2001. Vol. 33, N 2. P. 259 - 265.

85. Chang B.B. et al. The use of spliced vein bypasses for infrainguinal arterial reconstruction//J Vasc Surg. J Vasc Surg, 1995. Vol. 21, N 3. P. 403 - 412.

86. Albers M. et al. Meta-analysis of allograft bypass grafting to infrapopliteal arteries//European Journal of Vascular and Endovascular Surgery. 2004. Vol. 28, N 5. P. 462 - 472.

87. Guevara-Noriega K.A., Lucar-Lopez G.A., Pomar J.L. Cryopreserved Allografts for Treatment of Chronic Limb-Threatening Ischemia in Patients Without Autologous Saphenous Veins//Ann Vasc Surg. Elsevier Inc., 2019. Vol. 60. P. 379 - 387.

88. Gisbertz S.S. et al. Remote endarterectomy versus supragenicular bypass surgery for long occlusions of the superficial femoral artery: Medium-term results of a randomized controlled trial (The REVAS trial)//Ann Vasc Surg. 2010. Vol. 24, N 8. P. 1015 - 1023.

89. Saaya S. et al. A prospective randomized trial on endovascular recanalization with stenting versus remote endarterectomy for the superficial femoral artery total occlusive lesions//J Vasc Surg. Elsevier Inc., 2022. Vol. 76, N 1. P. 158 - 164.

90. Mohapatra A. et al. Nationwide trends in drug-coated balloon and drug-eluting stent utilization in the femoropopliteal arteries//Journal of Vascular Surgery. Mosby Inc., 2020. Vol. 71, N 2. P. 560 - 566.

91. Rastan A. et al. Stent placement vs. balloon angioplasty for popliteal artery treatment: Two-year results of a prospective, multicenter, randomized trial//Journal of Endovascular Therapy. Allen Press Inc., 2015. Vol. 22, N 1. P. 22 - 27.

92. Laird J.R. et al. Nitinol stent implantation versus balloon angioplasty for lesions in the superficial femoral artery and proximal popliteal artery: Twelve-month results from the RESILIENT randomized trial//Circ Cardiovasc Interv. 2010. Vol. 3, N 3. P. 267 - 276.

93. Lammer J. et al. Sustained Benefit at 2 Years for Covered Stents Versus Bare-Metal Stents in Long SFA Lesions: The VIASTAR Trial//Cardiovasc Intervent Radiol. Springer New York LLC, 2015. Vol. 38, N 1. P. 25 - 32.

94. Bertges D.J. et al. Registry Assessment of Peripheral Interventional Devices objective performance goals for superficial femoral and popliteal artery peripheral vascular interventions//J Vasc Surg. Mosby Inc., 2021. Vol. 73, N 5. P. 1702 - 1714.e11.

95. Giannopoulos S. et al. Safety and Efficacy of Drug-Coated Balloon Angioplasty for the Treatment of Chronic Limb-Threatening Ischemia: A Systematic Review and Meta-Analysis//Journal of Endovascular Therapy. SAGE Publications Inc., 2020. Vol. 27, N 4. P. 647 - 657.

96. Dake M.D. et al. Durable Clinical Effectiveness with Paclitaxel-Eluting Stents in the Femoropopliteal Artery: 5-Year Results of the Zilver PTX Randomized Trial//Circulation. Lippincott Williams and Wilkins, 2016. Vol. 133, N 15. P. 1472 - 1483.

97. Gray W.A. et al. A polymer-coated, paclitaxel-eluting stent (Eluvia) versus a polymer-free, paclitaxel-coated stent (Zilver PTX) for endovascular femoropopliteal intervention (IMPERIAL): a randomised, non-inferiority trial//The Lancet. Lancet Publishing Group, 2018. Vol. 392, N 10157. P. 1541 - 1551.

98. Y. et al. Efficacy of a Drug-Eluting Stent Versus Bare Metal Stents for Symptomatic Femoropopliteal Peripheral Artery Disease: Primary Results of the EMINENT Randomized Trial.//Circulation. 2022. P. 101161CIRCULATIONAHA122059606.

99. Bai H. et al. Comparison of Atherectomy to Balloon Angioplasty and Stenting for Isolated Femoropopliteal Revascularization//Ann Vasc Surg. Elsevier Inc., 2020. Vol. 69. P. 261 - 273.

100. Dippel E.J. et al. Randomized controlled study of excimer laser atherectomy for treatment of femoropopliteal in-stent restenosis: Initial results from the EXCITE ISR Trial (EXCImer laser randomized controlled study for treatment of FemoropopliTEal in-stent restenosis)//JACC Cardiovasc Interv. Elsevier Inc., 2015. Vol. 8, N 1. P. 92 - 101.

101. Moxey P.W. et al. Trends and outcomes after surgical lower limb revascularization in England//British Journal of Surgery. 2011. Vol. 98, N 10. P. 1373 - 1382.

102. Bluemn E.G. et al. Analysis of Thirty-Day Readmission after Infrainguinal Bypass//Ann Vasc Surg. Elsevier Inc., 2019. Vol. 61. P. 34 - 47.

103. Razavi M.K., Mustapha J.A., Miller L.E. Contemporary systematic review and meta-analysis of early outcomes with percutaneous treatment for infrapopliteal atherosclerotic disease//Journal of Vascular and Interventional Radiology. Elsevier Inc., 2014. Vol. 25, N 10. P. 1489 - 1496.e3.

104. Albers M. et al. Meta-analysis of popliteal-to-distal vein bypass grafts for critical ischemia//J Vasc Surg. Mosby Inc., 2006. Vol. 43, N 3.

105. Romiti M. et al. Meta-analysis of infrapopliteal angioplasty for chronic critical limb ischemia//J Vasc Surg. Mosby Inc., 2008. Vol. 47, N 5.

106. Kurianov P. et al. Popliteal Artery Angioplasty for Chronic Total Occlusions with versus without the Distal Landing Zone//Ann Vasc Surg. Ann Vasc Surg, 2020. Vol. 68. P. 417 - 425.

107. Bradbury A.W. et al. A vein bypass first versus a best endovascular treatment first revascularisation strategy for patients with chronic limb threatening ischaemia who required an infra-popliteal, with or without an additional more proximal infra-inguinal revascularisation procedure to restore limb perfusion (BASIL-2): an open-label, randomised, multicentre, phase 3 trial//Lancet. Lancet, 2023. Vol. 401, N 10390. P. 1798 - 1809.

108. Dalmia V. et al. Impact of tibial bypass conduit on long-term amputation-free survival and primary patency in the Vascular Quality Initiative//J Vasc Surg. Elsevier BV, 2021.

109. Albers M. et al. Meta-analysis of allograft bypass grafting to infrapopliteal arteries//European Journal of Vascular and Endovascular Surgery. 2004. Vol. 28, N 5. P. 462 - 472.

110. Albers M. et al. Meta-analysis of polytetrafluoroethylene bypass grafts to infrapopliteal arteries//J Vasc Surg. Mosby Inc., 2003. Vol. 37, N 6. P. 1263 - 1269.

111. Sigala F. et al. Long-term outcomes following 282 consecutive cases of infrapopliteal PTA and association of risk factors with primary patency and limb salvage//Vasc Endovascular Surg. 2012. Vol. 46, N 2. P. 123 - 130.

112. Hsu C.C.T. et al. Angioplasty versus stenting for infrapopliteal arterial lesions in chronic limb-threatening ischaemia//Cochrane Database of Systematic Reviews. John Wiley and Sons Ltd, 2018. Vol. 2018, N 12.

113. Wu R. et al. Drug-eluting balloon versus standard percutaneous transluminal angioplasty in infrapopliteal arterial disease: A meta-analysis of randomized trials//International Journal of Surgery. Elsevier Ltd, 2016. Vol. 35. P. 88 - 94.

114. Zia S. et al. Contemporary outcomes of infrapopliteal atherectomy with angioplasty versus balloon angioplasty alone for critical limb ischemia//Journal of Vascular Surgery. Mosby Inc., 2020. Vol. 71, N 6. P. 2056 - 2064.

115. Kokkinidis D.G. et al. Laser Atherectomy for Infrapopliteal Lesions in Patients With Critical Limb Ischemia//Cardiovascular Revascularization Medicine. Elsevier Inc., 2021. Vol. 23. P. 79 - 83.

116. Zhang J. et al. Systematic Review and Meta-Analysis of Drug-Eluting Balloon and Stent for Infrapopliteal Artery Revascularization//Vascular and Endovascular Surgery. SAGE Publications Inc., 2017. Vol. 51, N 2. P. 72 - 83.

117. Ascer E., Veith F.J., Affiliations G. Bypasses to plantar arteries and other tibial branches: an extended approach to limb salvage//J Vasc Surg. 1988. Vol. 8, N 4. 434 - 475 p.

118. Hughes K. et al. Bypass to plantar and tarsal arteries: An acceptable approach to limb salvage//J Vasc Surg. 2004. Vol. 40, N 6. P. 1149 - 1157.

119. Brochado-Neto F.C. et al. Vein bypasses to branches of pedal arteries//J Vasc Surg. 2012. Vol. 55, N 3. P. 746 - 752.

120. Machin M. et al. Systematic review of inframalleolar endovascular interventions and rates of limb salvage, wound healing, restenosis, rest pain, reintervention and complications//Vascular. SAGE Publications Ltd, 2021.

121. Jung H.W. et al. Editor's Choice - Impact of Endovascular Pedal Artery Revascularisation on Wound Healing in Patients With Critical Limb Ischaemia//European Journal of Vascular and Endovascular Surgery. W.B. Saunders Ltd, 2019. Vol. 58, N 6. P. 854 - 863.

122. Teymen B., S. Comparison of drug eluting balloon angioplasty to infrapopliteal artery critical lesions with or without additional pedal artery angioplasty in patients with diabetes mellitus and critical limb ischemia//J Interv Cardiol. Blackwell Publishing Inc., 2018. Vol. 31, N 3. P. 400 - 406.

123. Nakama T. et al. Clinical Outcomes of Pedal Artery Angioplasty for Patients With Ischemic Wounds: Results From the Multicenter RENDEZVOUS Registry//JACC Cardiovasc Interv. Elsevier Inc., 2017. Vol. 10, N 1. P. 79 - 90.

124. Ho V.T. et al. Open, percutaneous, and hybrid deep venous arterialization technique for no-option foot salvage//Journal of Vascular Surgery. Mosby Inc., 2020. Vol. 71, N 6. P. 2152 - 2160.

125. Lu X.W. et al. Meta-analysis of the Clinical Effectiveness of Venous Arterialization for Salvage of Critically Ischaemic Limbs//European Journal of Vascular and Endovascular Surgery. 2006. Vol. 31, N 5. P. 493 - 499.

126. Schmidt A. et al. Midterm Outcomes of Percutaneous Deep Venous Arterialization With a Dedicated System for Patients With No-Option Chronic Limb-Threatening Ischemia: The ALPS Multicenter Study//Journal of Endovascular Therapy. SAGE Publications Inc., 2020. Vol. 27, N 4. P. 658 - 665.

127. Schreve M.A. et al. Venous Arterialisation for Salvage of Critically Ischaemic Limbs: A Systematic Review and Meta-Analysis//European Journal of Vascular and Endovascular Surgery. W.B. Saunders Ltd, 2017. Vol. 53, N 3. P. 387 - 402.

128. Pokrovskii A et al. Arterialization of venous blood flow in the foot in the treatment of severe ischemia in patients with crural arterial occlusions and non-functioning plantar arch [Electronic resource]//Khirurgia (Mosk). 1990. P. 35 - 42. URL: https://pubmed.ncbi.nlm.nih.gov/2391935/ (accessed: 10.03.2023).

129. Acin F. et al. Primary nitinol stenting in femoropopliteal occlusive disease: a meta-analysis of randomized controlled trials//J Endovasc Ther. J Endovasc Ther, 2012. Vol. 19, N 5. P. 585 - 595.

130. Alexandrescu V.A. et al. Healing of Diabetic Neuroischemic Foot Wounds With vs Without Wound-Targeted Revascularization: Preliminary Observations From an 8-Year Prospective Dual-Center Registry//Journal of Endovascular Therapy. SAGE Publications Inc., 2020. Vol. 27, N 1. P. 20 - 30.

131. Fossaceca R. et al. Endovascular treatment of diabetic foot in a selected population of patients with below-the-knee disease: Is the angiosome model effective?//Cardiovasc Intervent Radiol. 2013. Vol. 36, N 3. P. 637 - 644.

132. Jeon E.Y. et al. Clinical outcome of angiosome-oriented infrapopliteal percutaneous transluminal angioplasty for isolated infrapopliteal lesions in patients with critical limb ischemia//Diagnostic and Interventional Radiology. AVES Ibrahim Kara, 2016. Vol. 22, N 1. P. 52 - 58.

133. Iida O. et al. Importance of the angiosome concept for endovascular therapy in patients with critical limb ischemia//Catheterization and Cardiovascular Interventions. 2010. Vol. 75, N 6. P. 830 - 836.

134. de Athayde Soares R. et al. Concept of Angiosome Does Not Affect Limb Salvage in Infrapopliteal Angioplasty//Ann Vasc Surg. Elsevier Inc., 2016. Vol. 32. P. 34 - 40.

135. M. et al. Angiosome-targeted infrapopliteal endovascular revascularization for treatment of diabetic foot ulcers//J Vasc Surg. 2013. Vol. 57, N 2. P. 427 - 435.

136. Kurianov P. et al. Propensity-matched analysis does not support angiosome-guided revascularization of multilevel peripheral artery disease (PAD)//Vasc Med. Vasc Med, 2022. Vol. 27, N 1. P. 47 - 54.

137. F. et al. Results of infrapopliteal endovascular procedures performed in diabetic patients with critical limb ischemia and tissue loss from the perspective of an angiosome-oriented revascularization strategy//Int J Vasc Med. 2014. Vol. 2014.

138. Ebaugh J.L. et al. Comparison of costs of staged versus simultaneous lower extremity arterial hybrid procedures//Am J Surg. 2008. Vol. 196, N 5. P. 634 - 640.

139. Fereydooni A. et al. Rapid increase in hybrid surgery for the treatment of peripheral artery disease in the Vascular Quality Initiative database//J Vasc Surg. Mosby Inc., 2020. Vol. 72, N 3. P. 977 - 986.e1.

140. Ray F.S. et al. Femoropopliteal saphenous vein bypass grafts. Analysis of 150 cases//Am J Surg. Am J Surg, 1970. Vol. 119, N 4. P. 385 - 391.

141. Chang R.W. et al. Long-term results of combined common femoral endarterectomy and iliac stenting/stent grafting for occlusive disease//J Vasc Surg. 2008. Vol. 48, N 2. P. 362 - 367.

142. Zavatta M., Mell M.W. A national Vascular Quality Initiative database comparison of hybrid and open repair for aortoiliac-femoral occlusive disease//J Vasc Surg. Mosby Inc., 2018. Vol. 67, N P. 199 - 205.e1.

143. Starodubtsev V. et al. Better treatment option in chronic superficial femoral artery occlusive disease: comparison of methods (meta-analysis)//J Cardiovasc Thorac Res. Maad Rayan Publishing Company, 2019. Vol. 11, N 3. P. 224 - 229.

144. Mccoy D.M. et al. The role of isolated profundaplasty for the treatment of rest pain//Arch Surg. Arch Surg, 1989. Vol. 124, N 4. P. 441 - 444.

145. Fugger R. et al. The Place of Profundaplasty in the Surgical Treatment of Superficial Femoral Artery Occlusion//EurJ Vasc Surg. 1987. Vol. 1. 187 - 191 p.

146. Jamil Z. et al. Revascularization of the profunda femoris artery for limb salvage//Am Surg. Am Surg, 1984. Vol. 50, N 2. P. 109 - 111.

147. Akamatsu D. et al. Efficacy of iliac inflow repair in patients with concomitant iliac and superficial femoral artery occlusive disease//Asian J Surg. Elsevier (Singapore) Pte Ltd, 2017. Vol. 40, N 6. P. 475 - 480.

148. Barral X. et al. Bypass to the perigeniculate collateral vessels. A useful technique for limb salvage: preliminary report on 22 patients//J Vasc Surg. J Vasc Surg, 1998. Vol. 27, N 5. P. 928 - 935.

149. de Latour B. et al. Bypass to the Perigeniculate Collateral Arteries: Mid-term Results//European Journal of Vascular and Endovascular Surgery. 2008. Vol. 35, N 4. P. 473 - 479.

150. de Luccia N. et al. Limb salvage using bypass to the perigeniculate arteries//European Journal of Vascular and Endovascular Surgery. W.B. Saunders Ltd, 2011. Vol. 42, N 3. P. 374 - 378.

151. Kang G. Endovascular approach to iliac artery stenosis and restenosis//Indian Heart Journal. Elsevier B.V., 2015. Vol. 67, N 6. P. 514 - 517.

152. Bekken J.A. et al. Covered Stents vs. Angioplasty for Common Iliac Artery In Stent Restenosis: A Retrospective Comparison//European Journal of Vascular and Endovascular Surgery. W.B. Saunders Ltd, 2021.

153. Tsetis D. et al. Preliminary Experience With Cutting Balloon Angioplasty for Iliac Artery In-Stent Restenosis//J Endovasc Ther. 2008. Vol. 15. 193 - 202 p.

154. Stahlhoff S. et al. Drug-eluting vs standard balloon angioplasty for iliac stent restenosis: Midterm results//Journal of Endovascular Therapy. Allen Press Inc., 2015. Vol. 22, N 3. P. 314 - 318.

155. Cassese S. et al. Drug-coated balloon angioplasty for femoropopliteal in-stent restenosis: The repair cooperation: A meta-analysis of individual participant data from 3 randomized trials//Circ Cardiovasc Interv. Lippincott Williams and Wilkins, 2018. Vol. 11, N 12.

156. P. et al. Drug-Coated versus Plain Balloon Angioplasty in Bypass Vein Grafts (the DRECOREST I-Study)//Ann Vasc Surg. Elsevier Inc., 2019. Vol. 55. P. 36 - 44.

157. Orioli L. et al. Prevalence, Characteristics, and Prognosis of Peripheral Arterial Disease in Patients With Diabetic Charcot Foot//Journal of Foot and Ankle Surgery. Academic Press Inc., 2021. Vol. 60, N 6. P. 1158 - 1163.

158. Wukich D.K., Raspovic K.M., Suder N.C. Prevalence of Peripheral Arterial Disease in Patients With Diabetic Charcot Neuroarthropathy//Journal of Foot and Ankle Surgery. Academic Press Inc., 2016. Vol. 55, N 4. P. 727 - 731.

159. Waibel F.W. et al. Treatment Failures in Diabetic Foot Osteomyelitis Associated with Concomitant Charcot Arthropathy: The Role of Underlying Arteriopathy//International Journal of Infectious Diseases. Elsevier B.V., 2022. Vol. 114. P. 15 - 20.

160. Cates N.K. et al. Peripheral Vascular Disease Diagnostic Related Outcomes in Diabetic Charcot Reconstruction//Journal of Foot and Ankle Surgery. Academic Press Inc., 2019. Vol. 58, N 6. P. 1058 - 1063.

161. , Sincer., Erdal E. Catheter-directed intra-arterial thrombolysis for lower extremity arterial occlusions//Anatolian Journal of Cardiology. Turkish Society of Cardiology, 2019. Vol. 22, N 2. P. 54 - 59.

162. Vanheer R. et al. A comprehensive report of long-term outcomes after catheter-directed thrombolysis for occluded infrainguinal bypass grafts//J Vasc Surg. Mosby Inc., 2019. Vol. 70, N 4. P. 1205 - 1216.

163. Schrijver A.M. et al. Long-Term Outcomes of Catheter-Directed Thrombolysis for Acute Lower Extremity Occlusions of Native Arteries and Prosthetic Bypass Grafts//Ann Vasc Surg. Elsevier Inc., 2016. Vol. 31. P. 134 - 142.

164. Kuoppala M., , Acosta S. Outcome after thrombolysis for occluded endoprosthesis, bypasses and native arteries in patients with lower limb ischemia//Thromb Res. Elsevier Ltd, 2014. Vol. 134, N 1. P. 23 - 28.

165. Comerota A.J. et al. Results of a prospective, randomized trial of surgery versus thrombolysis for occluded lower extremity bypass grafts//Am J Surg. Am J Surg, 1996. Vol. 172, N 2. P. 105 - 112.

166. Weaver F.A. et al. Surgical revascularization versus thrombolysis for nonembolic lower extremity native artery occlusions: results of a prospective randomized trial. The STILE Investigators. Surgery versus Thrombolysis for Ischemia of the Lower Extremity//J Vasc Surg. J Vasc Surg, 1996. Vol. 24, N 4. P. 513 - 523.

167. Consensus on thrombolysis. Thrombolysis in the Management of Lower Limb Peripheral Arterial Occlusion-A Consensus Document* Working Party on Thrombolysis in the Management of Limb Ischemia DEFINITION AND OBJECTIVE OF THROMBOLYTIC TREATMENT.

168. Giannakakis S. et al. Thrombolysis in peripheral artery disease//Therapeutic Advances in Cardiovascular Disease. SAGE Publications Ltd, 2017. Vol. 11, N 4. P. 125 - 132.

169. Woo K. et al. Use of completion imaging during infrainguinal bypass in the Vascular Quality Initiative//J Vasc Surg. Mosby Inc., 2015. Vol. 61, N 5. P. 1258 - 1263.

170. Woo K. et al. Outcomes of completion imaging for lower extremity bypass in the Vascular Quality Initiative//Journal of Vascular Surgery. Mosby Inc., 2015. Vol. 62, N 2. P. 412 - 416.

171. Normahani P. et al. Applications of intraoperative Duplex ultrasound in vascular surgery: a systematic review//Ultrasound Journal. Springer-Verlag Italia s.r.l., 2021. Vol. 13, N 1.

172. Lipsky B.A. et al. 2012 infectious diseases society of America clinical practice guideline for the diagnosis and treatment of diabetic foot infections//Clinical Infectious Diseases. 2012. Vol. 54, N 12.

173. Vas P.R.J. et al. The Diabetic Foot Attack: "'Tis Too Late to Retreat!"//International Journal of Lower Extremity Wounds. SAGE Publications Inc., 2018. Vol. 17, N 1. P. 7 - 13.

174. Tan J.S. et al. Can Aggressive Treatment of Diabetic Foot Infections Reduce the Need for Above-Ankle Amputation?//Clinical Infectious Diseases. 1996. Vol. 23. 286-91 p.

175. Faglia E. et al. The Role of Early Surgical Debridement and Revascularization in Patients With Diabetes and Deep Foot Space Abscess: Retrospective Review of 106 Patients With Diabetes//Journal of Foot and Ankle Surgery. 2006. Vol. 45, N 4. P. 220 - 226.

176. Shannon A.H. et al. Impact of the Timing of Foot Tissue Resection on Outcomes in Patients Undergoing Revascularization for Chronic Limb-Threatening Ischemia//Angiology. SAGE Publications Inc., 2021. Vol. 72, N 2. P. 159 - 165.

177. Shiraki T. et al. Predictors of delayed wound healing after endovascular therapy of isolated infrapopliteal lesions underlying critical limb ischemia in patients with high prevalence of diabetes mellitus and hemodialysis//European Journal of Vascular and Endovascular Surgery. W.B. Saunders Ltd, 2015. Vol. 49, N 5. P. 565 - 573.

178. Flores A.M. et al. Benefit of multidisciplinary wound care center on the volume and outcomes of a vascular surgery practice//Journal of Vascular Surgery. Mosby Inc., 2019. Vol. 70, N 5. P. 1612 - 1619.

179. Haug V. et al. Combined (endo-)vascular intervention and microsurgical lower extremity free flap reconstruction-A propensity score matching analysis in 5386 ACS-NSQIP patients//Journal of Plastic, Reconstructive and Aesthetic Surgery. Churchill Livingstone, 2021. Vol. 74, N 5. P. 1031 - 1040.

180. Randon C. et al. A 15-Year Experience with Combined Vascular Reconstruction and Free Flap Transfer for Limb-Salvage//European Journal of Vascular and Endovascular Surgery. 2009. Vol. 38, N 3. P. 338 - 345.

181. Baumeister S. et al. Stellenwert der plastischen chirurgie im interdisziplin ren therapiekonzept diabetischer ulzera am fu//Deutsche Medizinische Wochenschrift. 2004. Vol. 129, N 13. P. 676 - 680.

182. Clerici G. et al. The use of a dermal substitute to preserve maximal foot length in diabetic foot wounds with tendon and bone exposure following urgent surgical debridement for acute infection Dermal substitute for diabetic foot wounds//International Wound Journal -. 2010. Vol. 7, N 3. 176 - 183 p.

183. Blume P.A. et al. Comparison of Negative Pressure Wound Therapy Using Vacuum-Assisted Closure With Advanced Moist Wound Therapy in the Treatment of Diabetic Foot Ulcers A multicenter randomized controlled trial. 2008.

184. Attinger C.E. et al. The role of intrinsic muscle flaps of the foot for bone coverage in foot and ankle defects in diabetic and nondiabetic patients//Plast Reconstr Surg. Plast Reconstr Surg, 2002. Vol. 110, N 4. P. 1047 - 1054.

185. Gkotsoulias E. Split Thickness Skin Graft of the Foot and Ankle Bolstered With Negative Pressure Wound Therapy in a Diabetic Population: The Results of a Retrospective Review and Review of the Literature//Foot Ankle Spec. SAGE Publications Ltd, 2020. Vol. 13, N 5. P. 383 - 391.

186. OHTAS-NPWT. Negative Pressure Wound Therapy An EvidenceBased Analysis. 2006.

187. Tukiainen E., Biancari F., Lep ntalo M. Lower limb revascularization and free flap transfer for major ischemic tissue loss//World J Surg. 2000. Vol. 24, N 12. P. 1531 - 1536.

188. Igari K. et al. Combined Arterial Reconstruction and Free Tissue Transfer for Patients with Critical Limb Ischemia//Ann Vasc Dis. The Editorial Committee of Annals of Vascular Diseases, 2013. Vol. 6, N 4. P. 706 - 710.

189. Li X. et al. Reconstruction of the foot and ankle using pedicled or free flaps: Perioperative flap survival analysis//PLoS One. Public Library of Science, 2016. Vol. 11, N 12.

190. Kallio M. et al. Strategies for Free Flap Transfer and Revascularisation with Long-term Outcome in the Treatment of Large Diabetic Foot Lesions//European Journal of Vascular and Endovascular Surgery. W.B. Saunders Ltd, 2015. Vol. 50, N 2. P. 223 - 230.

191. Oh T.S., Lee H.S., Hong J.P. Diabetic foot reconstruction using free flaps increases 5-year-survival rate//Journal of Plastic, Reconstructive and Aesthetic Surgery. 2013. Vol. 66, N 2. P. 243 - 250.

192. Silva L.R. et al. Results of One-Stage or Staged Amputations of Lower Limbs Consequent to Critical Limb Ischemia and Infection//Ann Vasc Surg. Elsevier Inc., 2018. Vol. 46. P. 218 - 225.

193. Cheun T.J. et al. Short-term contemporary outcomes for staged versus primary lower limb amputation in diabetic foot disease//Journal of Vascular Surgery. Mosby Inc., 2020. Vol. 72, N P. 658 - 666.e2.

194. Tsvetkov V.O. et al. Two-phase amputation among critically ill patients with ischemic gangrene of lower limbs as a way to improve treatment outcome. Cohort study//Annals of Medicine and Surgery. Elsevier Ltd, 2020. Vol. 60. P. 587 - 591.

195. Fisher D.F. et al. One-stage versus two-stage amputation for wet gangrene of the lower extremity: A randomized study//J Vasc Surg. Elsevier BV, 1988. Vol. 8, N 4. P. 428 - 433.

196. Mcintyre K.E. et al. Guillotine Amputation in the Treatment of Nonsalvageable Lower-Extremity Infections. 1983.

197. Chopra A. et al. Ambulation and functional outcome after major lower extremity amputation//J Vasc Surg. Mosby Inc., 2018. Vol. 67, N 5. P. 1521 - 1529.

198. Suckow B.D. et al. Comparison of graft patency, limb salvage, and antithrombotic therapy between prosthetic and autogenous below-knee bypass for critical limb ischemia//Annals of Vascular Surgery. Elsevier Inc., 2013. Vol. 27, N 8. P. 1134 - 1145.

199. J rgensen H.R.I. et al. Selection of amputation level in ischemia: Skin blood flow and perfusion pressure equally predictive//Acta Orthop. Informa Healthcare, 1990. Vol. 61, N 1. P. 62 - 65.

200. Dowd. Predicting stump healing following amputation for peripheral vascular disease using the transcutaneous oxygen monitor - PubMed [Electronic resource]. URL: https://pubmed.ncbi.nlm.nih.gov/3566115/ (accessed: 23.02.2022).

201. , Rakovec S., . Determination of amputation level in ischaemic limbs using tcPO2 measurement//Vasa - Journal of Vascular Diseases. 2005. Vol. 34, N 2. P. 108 - 112.

202. Karkos C.D. et al. Subintimal recanalization of the femoropopliteal segment to promote healing of an ulcerated below-knee amputation stump//J Endovasc Ther. J Endovasc Ther, 2006. Vol. 13, N P. 420 - 423.

203. Ichihashi S. et al. Percutaneous deep venous arterialization at femoropopliteal segment for unhealed amputated stump ulcer after below the knee amputation//Catheterization and Cardiovascular Interventions. John Wiley and Sons Inc, 2021. Vol. 98, N 1. P. E124 - E126.

204. Poi M.J. et al. Percutaneous profunda femoris artery revascularization to prevent hip disarticulation: case series and review of the literature//Am J Surg. Am J Surg, 2012. Vol. 204, N 5. P. 649 - 654.

205. Manouguian S. [Revascularization of the profunda femoris artery in ischemia of the stump after above knee amputation]//Zentralbl Chir. Zentralbl Chir, 2001. Vol. 126, N 2. P. 157 - 160.

206. Sanni A., Hamid A., Dunning J. Is sympathectomy of benefit in critical leg ischaemia not amenable to revascularisation?//Interact Cardiovasc Thorac Surg. 2005. Vol. 4, N 5. P. 478 - 483.

207. Ubbink D.T., Vermeulen H. Spinal cord stimulation for non-reconstructable chronic critical leg ischaemia//Cochrane Database of Systematic Reviews. John Wiley and Sons Ltd, 2013. Vol. 2013, N 2.

208. Vietto V. et al. Prostanoids for critical limb ischaemia//Cochrane Database of Systematic Reviews. John Wiley and Sons Ltd, 2018. Vol. 2018, N 1.

209. Brande. Intravenous pentoxifylline for the treatment of chronic critical limb ischaemia. The European Study Group//Eur J Vasc Endovasc Surg. Eur J Vasc Endovasc Surg, 1995. Vol. 9, N P. 426 - 436.

210. Myhre H.O. et al. Efficacy and clinical tolerance of parenteral pentoxifylline in the treatment of critical lower limb ischemia. A placebo controlled multicenter study. Norwegian Pentoxifylline Multicenter Trial Group//Int Angiol. Int Angiol, 1996. Vol. 15, N 1. P. 75 - 80.

211. Forster R. et al. Gene therapy for peripheral arterial disease//Cochrane Database of Systematic Reviews. John Wiley and Sons Ltd, 2018. Vol. 2018, N 10.

212. Houghton J.S. et al. Associations of Clinical Frailty with Severity of Limb Threat and Outcomes in Chronic Limb-threatening Ischaemia//Ann Vasc Surg. Elsevier Inc., 2021. Vol. 76. P. 406 - 416.

213. Ruemenapf G., Morbach S., Sigl M. Therapeutic Alternatives in Diabetic Foot Patients without an Option for Revascularization: A Narrative Review//Journal of Clinical Medicine. MDPI, 2022. Vol. 11, N 8.

214. Sibona A. et al. A single center's 15-year experience with palliative limb care for chronic limb threatening ischemia in frail patients//Journal of Vascular Surgery. Elsevier Inc., 2022. Vol. 75, N 3. P. 1014 - 1020.e1.

215. Suckow B.D. et al. Predicting functional status following amputation after lower extremity bypass//Annals of Vascular Surgery. 2012. Vol. 26, N 1. P. 67 - 78.

216. Webster J.B. et al. Prosthetic fitting, use, and satisfaction following lower-limb amputation: A prospective study//J Rehabil Res Dev. 2012. Vol. 49, N 10. P. 1493 - 1504.

217. Catalano M. et al. Prevention of serious vascular events by aspirin amongst patients with peripheral arterial disease: randomized, double-blind trial//J Intern Med. J Intern Med, 2007. Vol. 261, N 3. P. 276 - 284.

218. Anand S.S. et al. Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial//The Lancet. Lancet Publishing Group, 2018. Vol. 391, N 10117. P. 219 - 229.

219. Willems L.H. et al. Antithrombotic Therapy for Symptomatic Peripheral Arterial Disease: A Systematic Review and Network Meta-Analysis//Drugs. Drugs, 2022. Vol. 82, N 12. P. 1287 - 1302.

220. Bonaca M.P. et al. Rivaroxaban in Peripheral Artery Disease after Revascularization//New England Journal of Medicine. Massachusetts Medical Society, 2020. Vol. 382, N 21. P. 1994 - 2004.

221. Hiatt W.R. et al. Rivaroxaban and Aspirin in Peripheral Artery Disease Lower Extremity Revascularization: Impact of Concomitant Clopidogrel on Efficacy and Safety//Circulation. Circulation, 2020. Vol. 142, N 23. P. 2219 - 2230.

222. Tepe G. et al. Management of peripheral arterial interventions with mono or dual antiplatelet therapy--the MIRROR study: a randomised and double-blinded clinical trial//Eur Radiol. Eur Radiol, 2012. Vol. 22, N 9. P. 1998 - 2006.

223. Belch J.J.F., Dormandy J. Results of the randomized, placebo-controlled clopidogrel and acetylsalicylic acid in bypass surgery for peripheral arterial disease (CASPAR) trial//J Vasc Surg. Mosby Inc., 2010. Vol. 52, N 4. P. 825 - 833.e2.

224. Tangelder M.J.D. et al. Efficacy of oral anticoagulants compared with aspirin after infrainguinal bypass surgery (The Dutch Bypass Oral anticoagulants or Aspirin study): A randomised trial//Lancet. Elsevier B.V., 2000. Vol. 355, N 9201. P. 346 - 351.

225. Johnson W.C., Williford W.O. Benefits, morbidity, and mortality associated with long-term administration of oral anticoagulant therapy to patients peripheral arterial bypass procedures: A prospective randomized study//J Vasc Surg. Mosby Inc., 2002. Vol. 35, N 3. P. 413 - 421.

226. Sarac T.P. et al. Warfarin improves the outcome of infrainguinal vein bypass grafting at high risk for failure//J Vasc Surg. J Vasc Surg, 1998. Vol. 28, N 3. P. 446 - 457.

227. Willigendael E.M. et al. Smoking and the patency of lower extremity bypass grafts: A meta-analysis//J Vasc Surg. Mosby Inc., 2005. Vol. 42, N 1. P. 67 - 74.

228. Henke P.K. et al. Patients undergoing infrainguinal bypass to treat atherosclerotic vascular disease are underprescribed cardioprotective medications: Effect on graft patency, limb salvage, and mortality//J Vasc Surg. Mosby Inc., 2004. Vol. 39, N 2. P. 357 - 365.

229. Abbruzzese T.A. et al. Statin therapy is associated with improved patency of autogenous infrainguinal bypass grafts//J Vasc Surg. 2004. Vol. 39, N 6. P. 1178 - 1185.

230. Tomoi Y. et al. Efficacy of statin treatment after endovascular therapy for isolated below-the-knee disease in patients with critical limb ischemia//Cardiovasc Interv Ther. 2013. Vol. 28, N 4. P. 374 - 382.

231. Davies A.H. et al. Is duplex surveillance of value after leg vein bypass grafting? Principal results of the vein graft surveillance randomised trial (VGST)//Circulation. 2005. Vol. 112, N 13. P. 1985 - 1991.

232. Lundell A. et al. Femoropopliteal-crural graft patency is improved by an intensive surveillance program: A prospective randomized study//Swedish Medical Research Council. Vol. 00759.

233. Ihlberg L. et al. The utility of duplex scanning in infrainguinal vein graft surveillance: results from a randomised controlled study//Eur J Vasc Endovasc Surg. Eur J Vasc Endovasc Surg, 1998. Vol. 16, N 1. P. 19 - 27.

234. Abu Dabrh A.M. et al. The natural history of untreated severe or critical limb ischemia//Journal of Vascular Surgery. Mosby Inc., 2015. Vol. 62, N 6. P. 1642 - 1651.e3.

235. Leal C, Almeida N, Silva M, Santos A, Vasconcelos H, Figueiredo P. Appropriateness of Endoscopic Procedures: A Prospective, Multicenter Study. GE Port J Gastroenterol. 2021 May 25; 29(1): 5 - 12. doi: 10.1159/000515839. PMID: 35111959; PMCID: PMC8787496.

236. D'Oria M, Berchiolli R, Gargiulo M, Antonello M, Pratesi G, Michelagnoli S, Silingardi R, Isernia G, Veraldi GF, Tinelli G, Giudice R, Ippoliti A, Cappiello P, Martelli M, Lepidi S, Troisi N; OUTSTEPP2 Collaborative Study Group. Bypass vs endovascular treatment for occluded femoro-popliteal stents in patients with critical limb-threatening ischemia. J Vasc Surg. 2023 Nov; 78(5): 1270 - 1277. doi: 10.1016/j.jvs.2023.07.053. Epub 2023 Jul 31. PMID: 37532160.

237. Pleger SP, Nink N, Elzien M, Kunold A, Koshty A, Reduction of groin wound complications in vascular surgery patients using closed incision negative pressure therapy (ciNPT): a prospective, randomised, single-institution study. Int Wound J. 2018 Feb; 15(1): 75 - 83. doi: 10.1111/iwj.12836. Epub 2017 Oct 25. PMID: 29068153; PMCID: PMC7950196.

238. European Society for Vascular Surgery (ESVS) 2023 Clinical Practice Guidelines on Antithrombotic Therapy for Vascular Diseases